Article
Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL
28 Jul 2015
Abstract excerpt
The hypothesis that raising high-density lipoprotein cholesterol (HDL-C) levels could improve the risk for cardiovascular disease (CVD) is facing challenges. There is multitudinous clear clinical evidence that the latest failures of HDL-C-raising drugs show no clear association with risks for CVD. At the genetic level, recent research indicates that steady-state HDL-C concentrations may provide limited...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
